Price T Rowe Associates Inc Ptc Therapeutics, Inc. Transaction History

Price T Rowe Associates Inc

$816 Billion
Q1 2024

A detailed history of Price T Rowe Associates Inc transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 639,867 shares of PTCT stock, worth $19.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

639,867

Previous 998,303 35.9%

Holding current value

$19.6 Million

Previous $27.5 Million 32.35%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$24.15 - $31.95 $8.66 Million - $11.5 Million	-358,436 Reduced 35.9%	639,867 $18.6 Million
Q4 2023 Feb 14, 2024	SELL	$18.07 - $29.37 $1.88 Million - $3.06 Million	-104,142 Reduced 9.45%	998,303 $27.5 Million
Q3 2023 Nov 14, 2023	SELL	$22.41 - $41.99 $21.8 Million - $40.9 Million	-974,489 Reduced 46.92%	1,102,445 $24.7 Million
Q2 2023 Aug 14, 2023	BUY	$40.4 - $59.1 $14.5 Million - $21.2 Million	359,169 Added 20.91%	2,076,934 $84.5 Million
Q1 2023 May 15, 2023	BUY	$38.16 - $48.86 $16.5 Million - $21.2 Million	433,376 Added 33.74%	1,717,765 $83.2 Million

Q4 2022 Feb 14, 2023	SELL	$33.53 - $54.79 $6.13 Million - $10 Million	-182,804 Reduced 12.46%	1,284,389 $49 Million
Q3 2022 Nov 14, 2022	SELL	$41.85 - $53.85 $7.27 Million - $9.36 Million	-173,793 Reduced 10.59%	1,467,193 $73.7 Million
Q2 2022 Aug 15, 2022	SELL	$25.6 - $45.23 $1.98 Million - $3.5 Million	-77,472 Reduced 4.51%	1,640,986 $65.7 Million
Q1 2022 May 16, 2022	SELL	$33.33 - $44.6 $12.9 Million - $17.3 Million	-388,103 Reduced 18.42%	1,718,458 $64.1 Million
Q4 2021 Feb 14, 2022	BUY	$35.36 - $41.86 $53,075 - $62,831	1,501 Added 0.07%	2,106,561 $83.9 Million
Q3 2021 Nov 15, 2021	SELL	$37.01 - $44.74 $281,572 - $340,381	-7,608 Reduced 0.36%	2,105,060 $78.3 Million
Q2 2021 Aug 16, 2021	SELL	$37.95 - $49.37 $1.68 Million - $2.18 Million	-44,206 Reduced 2.05%	2,112,668 $89.3 Million
Q1 2021 May 17, 2021	SELL	$46.8 - $68.92 $2.72 Million - $4.01 Million	-58,143 Reduced 2.62%	2,156,874 $102 Million
Q4 2020 Feb 16, 2021	BUY	$47.96 - $67.64 $106 Million - $150 Million	2,215,017 New	2,215,017 $135 Million

Others Institutions Holding PTCT

# of Institutions

198

Shares Held

83.7M

Call Options Held

192K

Put Options Held

129K

View Full List

About PTC THERAPEUTICS, INC.

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $2.19B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

More about PTCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Ptc Therapeutics, Inc. Transaction History